In Vitro and in vivo activities of dicationic diguanidino compounds against echinococcus multilocularis metacestodes

Tatiana Küster, Nadja Kriegel, David W. Boykin, Chad E. Stephens, Andrew Hemphill

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Alveolar echinococcosis (AE) is a disease predominantly affecting the liver, with metacestodes (larvae) of the tapeworm Echinococcus multilocularis proliferating and exhibiting tumor-like infiltrative growth. For many years, chemotherapeutical treatment against alveolar echinococcosis has relied on the benzimidazoles albendazole and mebendazole, which require long treatment durations and exhibit parasitostatic rather than parasiticidal efficacy. Although benzimidazoles have been and still are beneficial for the patients, there is clearly a demand for alternative and more efficient treatment options. Aromatic dications, more precisely a small panel of di-N-aryl-diguanidino compounds, were screened for efficacy against E. multilocularis metacestodes in vitro. Only those with a thiophene core group were active against metacestodes, while furans were not. The most active compound, DB1127, was further investigated in terms of in vivo efficacy in mice experimentally infected with E. multilocularis metacestodes. This diguanidino compound was effective against AE when administered intraperitoneally but not when applied orally. Thus, thiophene-diguanidino derivatives with improved bioavailability when administered orally could lead to treatment options against AE.

Original languageEnglish (US)
Pages (from-to)3829-3835
Number of pages7
JournalAntimicrobial Agents and Chemotherapy
Volume57
Issue number8
DOIs
StatePublished - Aug 1 2013

Fingerprint

Echinococcus multilocularis
Benzimidazoles
Thiophenes
Mebendazole
Furans
Albendazole
Cestoda
Therapeutics
Biological Availability
Larva
Alveolar echinococcosis
In Vitro Techniques
Liver
Growth
Neoplasms

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Infectious Diseases

Cite this

In Vitro and in vivo activities of dicationic diguanidino compounds against echinococcus multilocularis metacestodes. / Küster, Tatiana; Kriegel, Nadja; Boykin, David W.; Stephens, Chad E.; Hemphill, Andrew.

In: Antimicrobial Agents and Chemotherapy, Vol. 57, No. 8, 01.08.2013, p. 3829-3835.

Research output: Contribution to journalArticle

Küster, Tatiana ; Kriegel, Nadja ; Boykin, David W. ; Stephens, Chad E. ; Hemphill, Andrew. / In Vitro and in vivo activities of dicationic diguanidino compounds against echinococcus multilocularis metacestodes. In: Antimicrobial Agents and Chemotherapy. 2013 ; Vol. 57, No. 8. pp. 3829-3835.
@article{6b2a143831d94a9bba39ae27e8936b23,
title = "In Vitro and in vivo activities of dicationic diguanidino compounds against echinococcus multilocularis metacestodes",
abstract = "Alveolar echinococcosis (AE) is a disease predominantly affecting the liver, with metacestodes (larvae) of the tapeworm Echinococcus multilocularis proliferating and exhibiting tumor-like infiltrative growth. For many years, chemotherapeutical treatment against alveolar echinococcosis has relied on the benzimidazoles albendazole and mebendazole, which require long treatment durations and exhibit parasitostatic rather than parasiticidal efficacy. Although benzimidazoles have been and still are beneficial for the patients, there is clearly a demand for alternative and more efficient treatment options. Aromatic dications, more precisely a small panel of di-N-aryl-diguanidino compounds, were screened for efficacy against E. multilocularis metacestodes in vitro. Only those with a thiophene core group were active against metacestodes, while furans were not. The most active compound, DB1127, was further investigated in terms of in vivo efficacy in mice experimentally infected with E. multilocularis metacestodes. This diguanidino compound was effective against AE when administered intraperitoneally but not when applied orally. Thus, thiophene-diguanidino derivatives with improved bioavailability when administered orally could lead to treatment options against AE.",
author = "Tatiana K{\"u}ster and Nadja Kriegel and Boykin, {David W.} and Stephens, {Chad E.} and Andrew Hemphill",
year = "2013",
month = "8",
day = "1",
doi = "10.1128/AAC.02569-12",
language = "English (US)",
volume = "57",
pages = "3829--3835",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "8",

}

TY - JOUR

T1 - In Vitro and in vivo activities of dicationic diguanidino compounds against echinococcus multilocularis metacestodes

AU - Küster, Tatiana

AU - Kriegel, Nadja

AU - Boykin, David W.

AU - Stephens, Chad E.

AU - Hemphill, Andrew

PY - 2013/8/1

Y1 - 2013/8/1

N2 - Alveolar echinococcosis (AE) is a disease predominantly affecting the liver, with metacestodes (larvae) of the tapeworm Echinococcus multilocularis proliferating and exhibiting tumor-like infiltrative growth. For many years, chemotherapeutical treatment against alveolar echinococcosis has relied on the benzimidazoles albendazole and mebendazole, which require long treatment durations and exhibit parasitostatic rather than parasiticidal efficacy. Although benzimidazoles have been and still are beneficial for the patients, there is clearly a demand for alternative and more efficient treatment options. Aromatic dications, more precisely a small panel of di-N-aryl-diguanidino compounds, were screened for efficacy against E. multilocularis metacestodes in vitro. Only those with a thiophene core group were active against metacestodes, while furans were not. The most active compound, DB1127, was further investigated in terms of in vivo efficacy in mice experimentally infected with E. multilocularis metacestodes. This diguanidino compound was effective against AE when administered intraperitoneally but not when applied orally. Thus, thiophene-diguanidino derivatives with improved bioavailability when administered orally could lead to treatment options against AE.

AB - Alveolar echinococcosis (AE) is a disease predominantly affecting the liver, with metacestodes (larvae) of the tapeworm Echinococcus multilocularis proliferating and exhibiting tumor-like infiltrative growth. For many years, chemotherapeutical treatment against alveolar echinococcosis has relied on the benzimidazoles albendazole and mebendazole, which require long treatment durations and exhibit parasitostatic rather than parasiticidal efficacy. Although benzimidazoles have been and still are beneficial for the patients, there is clearly a demand for alternative and more efficient treatment options. Aromatic dications, more precisely a small panel of di-N-aryl-diguanidino compounds, were screened for efficacy against E. multilocularis metacestodes in vitro. Only those with a thiophene core group were active against metacestodes, while furans were not. The most active compound, DB1127, was further investigated in terms of in vivo efficacy in mice experimentally infected with E. multilocularis metacestodes. This diguanidino compound was effective against AE when administered intraperitoneally but not when applied orally. Thus, thiophene-diguanidino derivatives with improved bioavailability when administered orally could lead to treatment options against AE.

UR - http://www.scopus.com/inward/record.url?scp=84880290547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880290547&partnerID=8YFLogxK

U2 - 10.1128/AAC.02569-12

DO - 10.1128/AAC.02569-12

M3 - Article

C2 - 23716058

AN - SCOPUS:84880290547

VL - 57

SP - 3829

EP - 3835

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 8

ER -